GSK-3β, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and disease [version 1; referees: 2 approved]

Michael Aschner, Megan Culbreth

Research output: Contribution to journal › Review article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'GSK-3β, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and disease [version 1; referees: 2 approved]'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds